SCHEMBL4324735

SCHEMBL4324735

[CH2]C(=O)c1cccc(CC)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.50
KAT6A Q92794 2/20 0.48
SMYD3 Q9H7B4 1/20 0.48
CNR2 P34972 1/20 0.48
LOXL2 Q9Y4K0 1/20 0.47
CYP4F2 P78329 3/20 0.46
CYP4A11 Q02928 3/20 0.46
MAPT P10636 1/20 0.45
FOLH1 Q04609 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11050526 0.85 KAT6A (0.50) KAT6ACNR2LOXL2CYP4F2CYP4A11
SCHEMBL45866 0.84 PARP1 (0.57) BCL2KAT6ASMYD3CNR2LOXL2
SCHEMBL11611076 0.83 CNR2 (0.62) BCL2KAT6ASMYD3CNR2LOXL2
Hydrochloric Acid SCHEMBL27603084 0.82 PARP1 (0.55) BCL2KAT6ASMYD3CNR2LOXL2
SCHEMBL11054704 0.82 CYP4F2 (0.51) CYP4F2CYP4A11
SCHEMBL46935 0.82 BCL2 (0.66) BCL2FOLH1SMN1; SMN2TP53PKM
SCHEMBL5687742 0.82 BCL2 (0.51) BCL2KAT6ASMYD3CNR2LOXL2
SCHEMBL30394310 0.82 BCL2 (0.66) BCL2FOLH1SMN1; SMN2TP53PKM
SCHEMBL334537 0.82 MAOB (0.53) BCL2KAT6ASMYD3CNR2LOXL2
SCHEMBL8099947 0.82 BCL2 (0.51) BCL2KAT6ASMYD3CNR2LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101817784-B Ethylene derivatives and pesticides containing said derivatives NISSAN CHEMICAL INDUSTRIES CO., LTD. (JP) 2012-02-01 CN disclosed
CN-101817784-A Ethene derivatives and the pesticides that contains this derivative NISSAN CHEMICAL IND LTD 2010-09-01 CN disclosed
US-7566683-B2 Ethylene derivatives and pesticides containing said derivatives NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-07-28 US disclosed
US-20070049495-A1 Ethylene derivatives and pesticides containing said derivatives NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2007-03-01 US disclosed
US-7037880-B2 Ethylene derivatives and pesticides containing said derivatives NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2006-05-02 US disclosed
CN-1763003-A Ethylene derivatives and pesticides containing the same NISSAN CHEMICAL IND LTD (JP) 2006-04-26 CN disclosed
CN-1227229-C Ethylene derivatives and pesticides containing the same NISSAN CHEMICAL IND LTD (JP) 2005-11-16 CN disclosed
US-20030216394-A1 Etylene derivatives and pesticides containing said derivatives NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2003-11-20 US disclosed
EP-1360901-A1 2,3-cyclic substituted derivatives of 3-hydroxyacrolein and 3-hydroxyacrylic acid as pesticides NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 2003-11-12 EP disclosed
EP-0913392-B1 ETHYLENE DERIVATIVES AND PEST CONTROLLING AGENTS NISSAN CHEMICAL IND LTD (JP) 2003-07-02 EP disclosed
US-4451481-A ANTICHOLESTEROL AGENTS SANKYO COMPANY LIMITED (JP) 1984-05-29 US disclosed
US-4447626-A TREATMENT OF HYPERCHOLESTEROLEMIA SANKYO COMPANY LIMITED (JP) 1984-05-08 US disclosed
US-4438277-A Hydronaphthalene derivatives SANKYO COMPANY, LIMITED (JP) 1984-03-20 US disclosed
EP-0076601-A1 Octahydronaphthalene derivatives and their preparation SANKYO COMPANY LIMITED (JP) 1983-04-13 EP disclosed
EP-0074222-A1 MB-530B derivatives, their preparation and pharmaceutical compositions containing them SANKYO COMPANY LIMITED (JP) 1983-03-16 EP disclosed
EP-0070649-A2 ML-236B Derivatives, a process for their preparation and pharmaceutical compositions containing them SANKYO COMPANY LIMITED (JP) 1983-01-26 EP disclosed
EP-0065843-A1 New M-4 and iso M-4 derivatives, their preparation and compositions containing them SANKYO COMPANY LIMITED (JP) 1982-12-01 EP disclosed
EP-0065835-A1 M-4 and iso M-4 derivatives, their preparation and compositions containing them SANKYO COMPANY LIMITED (JP) 1982-12-01 EP disclosed
US-4361515-A Antihyperlipemic dihydro-ML-236B derivatives, their preparation and use SANKYO COMPANY, LIMITED (JP) 1982-11-30 US disclosed
US-4137322-A ML-236B carboxylic acid derivatives and their use as antihyperlipemic agents SANKYO COMPANY LIMITED (JP) 1979-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216394-A1 Etylene derivatives and pesticides containing said derivatives DDT, ECE1, EBPL BCL2 416/4885KAT6A 4590/4885SMYD3 2231/4885
US-20070049495-A1 Ethylene derivatives and pesticides containing said derivatives DDT, ECE1, EBPL BCL2 492/4885KAT6A 4440/4885SMYD3 2455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.